Zheng Zhao Selected Research

Indicators and Reagents (Reagents)

7/2022	Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis.
11/2021	FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.
1/2021	High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.
1/2020	Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma.
1/2020	ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity.
10/2019	AIE Featured Inorganic-Organic Core@Shell Nanoparticles for High-Efficiency siRNA Delivery and Real-Time Monitoring.
1/2018	ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Zhao Research Topics

Disease

94	Neoplasms (Cancer) 01/2024 - 01/2010
45	Glioma (Gliomas) 10/2023 - 12/2013
15	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 12/2013
12	Infections 06/2023 - 11/2013
12	Neoplasm Metastasis (Metastasis) 09/2022 - 07/2017
8	Colorectal Neoplasms (Colorectal Cancer) 03/2020 - 10/2013
8	Body Weight (Weight, Body) 06/2019 - 07/2013
7	Inflammation (Inflammations) 01/2024 - 07/2014
6	Wounds and Injuries (Trauma) 05/2024 - 01/2022
6	Carcinogenesis 02/2024 - 01/2019
6	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 04/2011
6	COVID-19 01/2023 - 01/2020
6	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 02/2013
6	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2017
6	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
6	Ischemic Stroke 02/2021 - 10/2018
5	Carcinoma (Carcinomatosis) 02/2024 - 03/2010
5	Osteosarcoma (Osteogenic Sarcoma) 07/2023 - 01/2021
5	Pain (Aches) 01/2022 - 02/2013
4	Ankylosing Spondylitis 01/2023 - 12/2011
4	Brain Neoplasms (Brain Tumor) 12/2022 - 01/2019
4	Colonic Neoplasms (Colon Cancer) 10/2022 - 12/2017
4	Disease Progression 01/2022 - 03/2010
4	Stroke (Strokes) 02/2021 - 01/2019
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2016
4	Ischemia 01/2021 - 05/2011
3	Squamous Cell Carcinoma of Head and Neck 03/2024 - 10/2018
3	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 11/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 09/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 09/2011
3	Necrosis 03/2023 - 07/2018
3	Dementia (Dementias) 02/2023 - 12/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2016
3	Immunoglobulin G4-Related Disease 01/2023 - 06/2017
3	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 03/2021
3	Pathologic Processes 01/2021 - 09/2012
3	Reperfusion Injury 01/2021 - 05/2011
3	Adenocarcinoma of Lung 11/2020 - 01/2017
3	Prostatic Neoplasms (Prostate Cancer) 04/2018 - 07/2013

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 08/2023 - 12/2013
20	RNA (Ribonucleic Acid)IBA 04/2023 - 01/2017
17	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2012
16	Long Noncoding RNAIBA 01/2024 - 11/2015
15	Phosphotransferases (Kinase)IBA 10/2022 - 03/2012
12	MicroRNAs (MicroRNA)IBA 01/2024 - 10/2013
10	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 01/2019
8	CurcuminIBA 07/2023 - 01/2014
8	Messenger RNA (mRNA)IBA 10/2022 - 12/2013
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2020
7	Indicators and Reagents (Reagents)IBA 07/2022 - 01/2018
6	AntioxidantsIBA 03/2024 - 01/2014
6	Circular RNAIBA 10/2023 - 01/2019
6	Temozolomide (Temodar)FDA LinkGeneric 10/2023 - 01/2019
6	LipidsIBA 11/2022 - 04/2016
6	CreatinineIBA 11/2022 - 11/2019
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 03/2012
5	Neuroprotective AgentsIBA 10/2021 - 01/2018
5	C-Reactive ProteinIBA 01/2021 - 02/2013
4	HydrogelsIBA 04/2024 - 07/2021
4	Fibroins (Fibroin)IBA 07/2023 - 10/2016
4	LigandsIBA 01/2023 - 05/2017
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2019
4	CytokinesIBA 01/2021 - 12/2017
4	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 01/2021 - 05/2011
3	AMP-Activated Protein KinasesIBA 03/2024 - 01/2015
3	Immune Checkpoint InhibitorsIBA 12/2023 - 12/2021
3	polydopamineIBA 07/2023 - 01/2021
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023 - 01/2015
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023 - 01/2017
3	Therapeutic UsesIBA 01/2023 - 03/2016
3	GlucocorticoidsIBA 01/2023 - 06/2017
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 06/2020
3	Leflunomide (Arava)FDA LinkGeneric 01/2023 - 06/2017
3	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 12/2017
3	BerberineIBA 09/2022 - 04/2018
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2022 - 10/2019
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 10/2019
3	CalciumIBA 01/2021 - 11/2014
3	Opioid Peptides (Opioid Peptide)IBA 01/2021 - 05/2011
3	EnkephalinsIBA 01/2021 - 05/2011
3	MethyltransferasesIBA 01/2021 - 12/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 07/2020 - 01/2015
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 06/2016
3	Small Interfering RNA (siRNA)IBA 10/2019 - 04/2011
3	Peptides (Polypeptides)IBA 01/2019 - 09/2012
3	demethyleneberberineIBA 06/2016 - 01/2015
3	Sunitinib (Sutent)FDA Link 01/2013 - 03/2010
2	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2024
2	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2020
2	CholesterolIBA 03/2024 - 06/2016

Therapy/Procedure

45	Therapeutics 01/2024 - 11/2010
14	Immunotherapy 03/2024 - 05/2017
9	Drug Therapy (Chemotherapy) 01/2024 - 12/2017
6	Precision Medicine 12/2023 - 01/2018
6	Photothermal Therapy 12/2023 - 01/2020
3	Radiotherapy 01/2023 - 10/2019
3	Phototherapy (Light Therapy) 01/2023 - 06/2020
3	Ligation 01/2022 - 12/2008
3	Thrombectomy 02/2021 - 01/2019
3	Cannula 01/2016 - 05/2011